Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population

[1]  D. Gudbjartsson,et al.  Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease , 2016, Nature Genetics.

[2]  M. Woodward,et al.  Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis. , 2016, Atherosclerosis.

[3]  Shu-Fang Chang,et al.  Systematic Literature Review and Meta-Analysis of the Association of Sarcopenia With Mortality. , 2016, Worldviews on evidence-based nursing.

[4]  Rajiv,et al.  Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. , 2016, The New England journal of medicine.

[5]  J. Danesh,et al.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.

[6]  P. Joshi,et al.  Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies , 2016, European journal of preventive cardiology.

[7]  O. Kucuk,et al.  Carotenoids and non-alcoholic fatty liver disease. , 2015, Hepatobiliary surgery and nutrition.

[8]  F. Azizi,et al.  Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study , 2015, International journal of endocrinology and metabolism.

[9]  D. Panagiotakos,et al.  Hierarchical modelling of blood lipids’ profile and 10-year (2002–2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study , 2015, Lipids in Health and Disease.

[10]  F. Azizi,et al.  High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study. , 2015, Journal of clinical lipidology.

[11]  S. R. J. Kræmer,et al.  Socioeconomic inequality and mortality - a regional Danish cohort study , 2015, BMC Public Health.

[12]  Natalie Pafitis.  Reviewer acknowledgement 2014 , 2015, BMC Public Health.

[13]  S. Wild,et al.  An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality , 2015, Heart.

[14]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[15]  M. Bobák,et al.  Health Factors and Risk of All-Cause, Cardiovascular, and Coronary Heart Disease Mortality: Findings from the MONICA and HAPIEE Studies in Lithuania , 2014, PLoS ONE.

[16]  N. Wareham,et al.  Distribution of lipid parameters according to different socio-economic indicators- the EPIC-Norfolk prospective population study , 2014, BMC Public Health.

[17]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[18]  Anette Varbo,et al.  Triglycerides and cardiovascular disease , 2014, The Lancet.

[19]  P. Allotey,et al.  Addressing non-communicable diseases in Malaysia: an integrative process of systems and community , 2014, BMC Public Health.

[20]  Nathan D. Wong,et al.  Epidemiological studies of CHD and the evolution of preventive cardiology , 2014, Nature Reviews Cardiology.

[21]  S. Grundy,et al.  Triglyceride–to–High-Density-Lipoprotein-Cholesterol Ratio Is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men , 2014, Journal of Investigative Medicine.

[22]  Yu-ming Chen,et al.  Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies , 2013, Lipids in Health and Disease.

[23]  L. Bathum,et al.  Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: A population-based register study , 2013, Scandinavian journal of primary health care.

[24]  D. Rader,et al.  Genetics of Lipid Traits and Relationship to Coronary Artery Disease , 2013, Current Cardiology Reports.

[25]  M. Phillips,et al.  Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein* , 2013, The Journal of Biological Chemistry.

[26]  F. Azizi,et al.  Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study. , 2013, Clinical biochemistry.

[27]  D. Rader,et al.  Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P? , 2013, Clinical chemistry.

[28]  N. Sarrafzadegan,et al.  Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. , 2013, Archives of Iranian medicine.

[29]  A. Tamakoshi,et al.  Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan , 2012, Journal of the American Heart Association.

[30]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[31]  J. Gallacher,et al.  Lipid-related markers and cardiovascular disease prediction. , 2012, JAMA.

[32]  E. Rimm,et al.  Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease , 2012, Journal of the American Heart Association.

[33]  V. Montori,et al.  The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis , 2012, BMC Endocrine Disorders.

[34]  A. Sinclair,et al.  Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes , 2012, BMC Endocrine Disorders.

[35]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[36]  C. Furberg,et al.  A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.

[37]  F. Azizi,et al.  Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. , 2010, Metabolism: clinical and experimental.

[38]  J. I. Pedersen,et al.  Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study , 2010, European Journal of Epidemiology.

[39]  Bin Chen,et al.  A modified formula for calculating low-density lipoprotein cholesterol values , 2010, Lipids in Health and Disease.

[40]  Asaf Bitton,et al.  Growing epidemic of coronary heart disease in low- and middle-income countries. , 2010, Current problems in cardiology.

[41]  Nicholas J Wareham,et al.  Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. , 2009, Journal of the American College of Cardiology.

[42]  J. Danesh,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[43]  A. Ghasemi,et al.  Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[44]  Farzad Hadaegh,et al.  Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II , 2009, Trials.

[45]  E. Demerath,et al.  Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2008, Metabolism: clinical and experimental.

[46]  Varghese George,et al.  Can dysfunctional HDL explain high coronary artery disease risk in South Asians? , 2008, International journal of cardiology.

[47]  F. Hadaegh,et al.  C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. , 2007, International journal of cardiology.

[48]  M. Pencina,et al.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.

[49]  Michael J Pencina,et al.  Choice of time scale and its effect on significance of predictors in longitudinal studies , 2007, Statistics in medicine.

[50]  J. Harnek,et al.  Mild hypothermia reduces cardiac post-ischemic reactive hyperemia , 2007, BMC cardiovascular disorders.

[51]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[52]  M. Reilly,et al.  Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy , 2006, PLoS medicine.

[53]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[54]  R. Langer,et al.  Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study). , 2003, The American journal of cardiology.

[55]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[56]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[57]  A. Dyer,et al.  Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. , 2000, JAMA.

[58]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[59]  K. Kalantar-Zadeh,et al.  Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. , 2007, Journal of the American Society of Nephrology : JASN.

[60]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[61]  B. Ainsworth,et al.  Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ) - Short and long forms , 2005 .

[62]  R. Gibbons.  ACC/AHA guideline for management of patients with chronic stable angina , 2003 .